INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "ASS1 GENE INSERTION FOR THE TREATMENT OF CITRULLINEMIA TYPE I"

GENEVA, Dec. 31 -- REGENERON PHARMACEUTICALS, INC. (777 Old Saw Mill River RoadTarrytown, New York 10591) filed a patent application (PCT/US2025/034529) for "ASS1 GENE INSERTION FOR THE TREATMENT OF CITRULLINEMIA TYPE I" on Jun 20, 2025. With publication no. WO/2025/265017, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PEFANIS, Evangelos (c/o Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, New York 10591), SABIN, Leah (c/o Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, New York...